Cipher Pharmaceuticals (TSE:CPH) Stock Crosses Above Fifty Day Moving Average - Time to Sell?

Key Points

• Cipher Pharmaceuticals shares moved above their 50-day moving average, trading as high as C$18.10 before last changing hands at C$17.87.
• The company reported quarterly EPS of C$0.33 on revenue of C$17.39 million, with a strong net margin of 54.37% and return on equity of 24.23%.
• Valuation and balance-sheet metrics include a market cap of C$451.77 million, a P/E ratio of 17.02, and a debt-to-equity ratio of 4.36; analysts expect about 1.29 EPS for the current year.

Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) NASDAQ: CPHR passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$17.24 and traded as high as C$18.10. Cipher Pharmaceuticals shares last traded at C$17.87, with a volume of 20,443 shares.

Cipher Pharmaceuticals Stock Down 0.2%

The company has a debt-to-equity ratio of 4.36, a current ratio of 1.12 and a quick ratio of 2.67. The firm has a market capitalization of C$451.77 million, a PE ratio of 17.02 and a beta of 0.89. The company's fifty day simple moving average is C$17.24 and its 200-day simple moving average is C$15.54.

Cipher Pharmaceuticals (TSE:CPH - Get Free Report) NASDAQ: CPHR last issued its quarterly earnings results on Thursday, May 7th. The company reported C$0.33 earnings per share for the quarter. The business had revenue of C$17.39 million during the quarter. Cipher Pharmaceuticals had a return on equity of 24.23% and a net margin of 54.37%. On average, analysts forecast that Cipher Pharmaceuticals Inc. will post 1.2907348 EPS for the current year.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals TSX: CPH OTCQX: CPHRF is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.